Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Advanced Radiotherapy (ART) in Prostate Cancer Patients With Early Stage, Advanced, Metastatic and Relapsed Disease (PROST-ART)

NCT06546267 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06546267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06546267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Advanced Radiotherapy (ART) in Prostate Cancer Patients With Early Stage, Advanced, Metastatic and Relapsed Disease (PROST-ART)
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
February 14, 2022
Completion date
December 14, 2027
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer